- Home
- / Elysium Healthcare
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Elysium Healthcare financials data including stock price, CreditSafe score, income statement, balance sheet, and acquistions and subsidiaries.
Revenue
£97.2 M
FY, 2021
CreditSafe Score
?
Score changed on Jun 10, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| GBP | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|
| Revenue | 74.0M | 84.2M | 97.2M |
| Cost of goods sold | 63.5M | 76.6M | 89.0M |
| Gross profit | 10.5M | 7.7M | 8.2M |
| Gross profit margin, % | 14.2% | 9.1% | 8.4% |
| General and administrative expense | 24.8M | 26.2M | 33.7M |
| Operating expense total | 28.3M | 30.6M | 38.7M |
| Depreciation and amortization | 3.5M | 4.3M | 5.0M |
| EBIT | (14.3M) | (18.6M) | (25.6M) |
| EBIT margin, % | -19.2% | -22.1% | -26.3% |
| Interest expense | 386.0K | 449.0K | 482.0K |
| Pre tax profit | (14.6M) | (19.0M) | (26.1M) |
| Income tax expense | 1.4M | 161.0K | (129.0K) |
| Net Income | (16.0M) | (19.2M) | (25.9M) |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |